In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens
- 1 April 1998
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 10 (1), 23-30
- https://doi.org/10.1016/s0924-8579(98)00020-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Community-Acquired PneumoniaNew England Journal of Medicine, 1995
- Penicillin-resistant Streptococcus pneumoniae in Germany: Genetic relationship to clones from other European countriesJournal of Medical Microbiology, 1995
- The Prevalence of Drug-ResistantStreptococcus pneumoniaeIn AtlantaNew England Journal of Medicine, 1995
- Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, SpainNew England Journal of Medicine, 1995
- Bacteremia Due to Viridans Streptococci That Are Highly Resistant to Penicillin: Increase Among Neutropenic Patients with CancerClinical Infectious Diseases, 1995
- Activity of Quinolones against Gram-Positive CocciDrugs, 1995
- In Vitro Activity of Fluoroquinolones against Gram-Positive BacteriaDrugs, 1995
- Resistance to Erythromycin in Group A StreptococciNew England Journal of Medicine, 1992
- Outbreaks of Infections with Erythromycin-resistant Group A Streptococci in Child Day Care CentresScandinavian Journal of Infectious Diseases, 1990
- Erythromycin-resistant Streptococcus pyogenesJournal of Antimicrobial Chemotherapy, 1990